Abstract:The extracts from the roots of Salvia miltiorrhiza Bunge (Danshen) are widely and traditionally used in the treatment of angina pectoris, acute myocardial infarct, hyperlipidemia and stroke in China and other Asian countries. In this study, we have investigated the role of P-glycoprotein (P-gp) in the intestinal absorption of tanshinone IIA (TSA), a major active constituent of Danshen, using several in vitro and in vivo models. The oral bioavailability of TSA was about 2.9-3.4% in rats, with non-linear pharmacokinetics when its dosage increased. In a single pass rat intestinal perfusion model, the permeability coefficients (P(app)) based on TSA disappearance from the luminal perfusates (P(lumen)) were 6.2- to 7.2-fold higher (P < 0.01) than those based on drug appearance in mesenteric venous blood (P(blood)). The P(blood), but not P(lumen), was significantly increased when co-perfused with verapamil, or quinidine (both P-gp inhibitors). The uptake and efflux of TSA in confluent Caco-2 cells were significantly altered in the presence of verapamil, quinidine, MK-571, or probenecid. The transport of TSA across Caco-2 monolayers was pH-, temperature- and ATP-dependent. Furthermore, the transport from the apical (AP) to basolateral (BL) side of the Caco-2 monolayers was 3.3- to 8.5-fold lower than that from the BL to AP side, but such a polarized transport was attenuated by co-incubated verapamil or quinidine. A polarized transport was also observed in the control MDCKII cells and more apparent in MDR1-MDCKII monolayers, with the P(app) values of TSA in the BL-AP direction being 7- to 9-fold higher in MDR1-MDCKII monolayers than those in the control MDCKII cells. Moreover, TSA significantly inhibited P-gp-mediated transport of digoxin in P-gp-overexpressing membrane vesicles with an IC(50) of 2.6 microM, but stimulated vanadate-sensitive P-gp ATPase activity with estimated K(m) and V(max) values of 10.70 +/- 0.69 microM and 67.65 +/- 1.31 nmol/min/mg protein, respectively. TSA was extensively metabolized to tanshinone IIB (TSB), and two other oxidative metabolites in rat liver microsomes, but the formation rate of TSB in rat intestinal microsomes was only about 1/10 of that in liver microsomes. These findings indicate that TSA is a substrate and reversing agent for P-gp; and P-gp-mediated efflux of TSA into the gut lumen and the first-pass metabolism contribute to the low oral bioavailability. Further studies are needed to explore the role of other drug transporters and first-pass metabolism in the low bioavailability of TSA.

Schisandrin A and B Induce Organic Anion Transporting Polypeptide 1b1 Transporter Activity

Interaction of the Main Active Components in Shengmai Formula Mediated by Organic Anion Transporter 1 (OAT1).

Tanshinone IIA increases mRNA expression of efflux transporters in cultured human intestinal cell.

Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza.

Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line.

Role of P-glycoprotein in the Transport of Tanshinone I, One Active Triterpenoid from Salvia Miltiorrhiza

Interactions of oleanane pentacyclic triterpenoids with human organic anion transporting polypeptide 1B1 and 1B3

Utilizing Single- and Double-Transfected Cell Models Expressing Human Organic Anion Transporter 1 and Human Cytochrome P450 1A2 to Investigate the Interactions with Ingredients of Herbal Medicines

Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3

[The Interactions Between Natural Products and OATP1B1].

Role of P-glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia Miltiorrhiza Bunge.

Effects of natural products on the function of human organic anion transporting polypeptide 1B1

Influence of allicin on the function of organic anion transporting polypeptide 1B1

Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.

Interactions of 172 Plant Extracts with Human Organic Anion Transporter 1 (SLC22A6) and 3 (SLC22A8): a Study on Herb-Drug Interactions

Identification of natural products as modulators of OATP2B1 using LC-MS/MS to quantify OATP-mediated uptake

Complex Components of Shengmai Formula Interact with Organic Cation Transporter 2 (OCT2) in MDCK Cells

PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA

Modulation of Transporter Activity of OATP1B1 and OATP1B3 by the Major Active Components of Radix Ophiopogonis

Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases.

Multiple Circulating Saponins from Intravenous ShenMai Inhibit OATP1Bs in Vitro: Potential Joint Precipitants of Drug Interactions